Cited by 205Antifungal resistance and susceptibilityFungal Infections and StudiesFungal and yeast genetics research

Aspergillosis: Spectrum of Disease, Diagnosis, and Treatment

Barnes, Penelope D., Marr, Kieren A.·2006·Infectious Disease Clinics of North America

Abstract

Infections by Aspergillus species present a particular challenge. The organism, which is ubiquitous in the environment, causes allergic disease in otherwise healthy individuals and devastating disease in the immunosuppressed. This article examines the range of infections caused by Aspergillus species, the challenges of diagnosis, and current treatment options.

Integrity signals

Registry

Crossref · 10.1016/j.idc.2006.06.001

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Among patients with documented MRSA infections, delays of > 24-48 hours until antibiotic administration are associated with increased mortality in some studies, but not in others.

    “Among patients with documented MRSA infections, delays of > 24-48 hours until antibiotic administration are associated with increased mortality in some studies (143-147), but not in others (148-154).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Barnes, P. D., & Marr, K. A.
Affiliations
University of Washington (US)
Corresponding author
Marr, Kieren A.
Venue
Infectious Disease Clinics of North America
Publisher
Elsevier BV
Published
2006-09
Volume
20
Issue
3
Pages
545-561
ISSN
0891-5520 (ISSN-L)
OpenAlex
W1978974268
Cited by
205
References
9
Citations by year
2026: 2 · 2025: 5 · 2024: 13 · 2023: 11 · 2022: 9 · 2021: 30 · 2020: 11 · 2019: 10 · 2018: 15 · 2017: 5 · 2016: 7 · 2015: 12 · 2014: 8 · 2013: 8 · 2012: 8
FWCI
1.17
Type
journal article
Language
en
Open access
closed
Locations
  • Infectious Disease Clinics of North America (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
Keywords
aspergillosis, Aspergillus, allergic bronchopulmonary aspergillosis, invasive aspergillosis, immunosuppression, fungal infection diagnosis, antifungal therapy
MeSH terms
Antifungal Agents, Aspergillosis, Humans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review